Emerging Global Leader Award (K43 Independent Clinical Trial Required)
National Institutes of Health · Department of Health and Human Services · PAR-24-295
In plain English
National Institutes of Health (Department of Health and Human Services) is accepting applications for this grant until Dec 3, 2026 (22 days left).
The listing does not state award amounts or the number of awards.
Eligibility is described in the listing text (the "Others" category).
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Posted: open for applications |
|---|---|
| Close date | Dec 3, 2026 · 22 days left |
| Posted date | Oct 15, 2024 |
| Opportunity number | PAR-24-295 |
| Agency | National Institutes of Health (Department of Health and Human Services) |
| Funding instrument | Grant |
| Category | Education, Environment, Health |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | Not stated |
| Award floor (min per award) | Not stated |
| Estimated total program funding | Not stated |
| Expected number of awards | Not stated |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 93.113 – Environmental Health 93.172 – Human Genome Research 93.173 – Research Related to Deafness and Communication Disorders 93.233 – National Center on Sleep Disorders Research 93.242 – Mental Health Research Grants 93.279 – Drug Abuse and Addiction Research Programs 93.313 – NIH Office of Research on Women's Health 93.398 – Cancer Research Manpower 93.837 – Cardiovascular Diseases Research 93.838 – Lung Diseases Research 93.839 – Blood Diseases and Resources Research 93.840 – Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders |
| Last updated on Grants.gov | Oct 15, 2024 |
| Archive date | Jan 8, 2027 |
Who can apply
- Others (see the eligibility details in the listing)
Additional eligibility information (excerpt from the listing):
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). …
Description
Excerpt from the official synopsis on Grants.gov (shortened; read the full text on the official listing):
This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.
Read the full listing on Grants.gov → · Agency's announcement page
More Department of Health and Human Services grants closing soon
All →- 2days leftNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
More education grants closing soon
All →- 5days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 6days leftSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 7days leftEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 7days leftEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation